Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 05.10.2026 | Verkauf | 105,15 | 1.417 | 148.998 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 170,02 | 2 | 340 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 169,36 | 14 | 2.371 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 168,21 | 12 | 2.019 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 167,59 | 78 | 13.072 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 166,44 | 50 | 8.322 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 165,49 | 120 | 19.859 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 164,64 | 24 | 3.951 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 163,63 | 200 | 32.725 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 28.09.2026 | Verkauf | 1,10 | 22.523 | 24.820 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 2.666 | 321.626 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 8.333 | 1.005.293 | Form 4 |
| BLSH | Bliss Andrew | Director | 24.09.2026 | Verkauf | 40,10 | 100 | 4.010 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Verkauf | 125,00 | 3.333 | 416.625 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 24.09.2026 | Verkauf | 120,00 | 1.416 | 169.920 | Form 4 |
| BLSH | Bliss Andrew | Director | 23.09.2026 | Verkauf | 40,22 | 59.976 | 2.412.031 | Form 4 |
| BLSH | Bliss Andrew | Director | 22.09.2026 | Verkauf | 40,79 | 108.200 | 4.413.056 | Form 4 |
| BLSH | Bliss Andrew | Director | 21.09.2026 | Verkauf | 40,20 | 76.953 | 3.093.888 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 21.09.2026 | Verkauf | 1,19 | 21.009 | 25.022 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 21.09.2026 | Verkauf | 106,61 | 1.416 | 150.960 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,29 | 5.840 | 644.112 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,31 | 2.920 | 322.100 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,30 | 6.968 | 768.561 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,36 | 19.384 | 2.139.193 | Form 4 |
| BLBD | Sanfrey Jeffrey Scott | Chief Operating Officer | 16.09.2026 | Verkauf | 62,40 | 4.000 | 249.600 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 14.09.2026 | Verkauf | 1,43 | 17.731 | 25.267 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,00 | 2.666 | 261.268 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 101,49 | 3.143 | 318.989 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 100,78 | 2.010 | 202.559 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 99,57 | 1.500 | 149.352 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,64 | 1.680 | 165.708 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 101,44 | 7.214 | 731.793 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 100,58 | 2.531 | 254.570 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 99,57 | 2.456 | 244.547 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,63 | 4.465 | 440.389 | Form 4 |
| BLND | Venkatramani Srinivasan | Head of Product Tech & Cust Op | 11.09.2026 | Verkauf | 1,43 | 74.705 | 106.828 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 09.09.2026 | Verkauf | 100,00 | 10.000 | 1.000.000 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 09.09.2026 | Verkauf | 97,54 | 1.416 | 138.117 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,92 | 232 | 23.414 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,20 | 2.518 | 252.293 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 98,89 | 576 | 56.960 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 101,41 | 147 | 14.907 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,33 | 1.131 | 113.469 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 99,22 | 385 | 38.201 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,82 | 358 | 36.095 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,11 | 2.997 | 300.040 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 99,00 | 614 | 60.785 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,83 | 775 | 78.142 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 100,12 | 8.285 | 829.517 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 98,97 | 1.944 | 192.390 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 08.09.2026 | Verkauf | 96,47 | 38 | 3.666 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 08.09.2026 | Verkauf | 198,09 | 2.700 | 534.845 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 08.09.2026 | Verkauf | 197,36 | 8.752 | 1.727.275 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 08.09.2026 | Verkauf | 196,54 | 6.058 | 1.190.642 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 08.09.2026 | Verkauf | 195,62 | 6.090 | 1.191.325 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 08.09.2026 | Verkauf | 194,33 | 2.400 | 466.399 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 08.09.2026 | Verkauf | 198,05 | 2.562 | 507.392 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 08.09.2026 | Verkauf | 197,23 | 4.605 | 908.244 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 08.09.2026 | Verkauf | 196,47 | 4.475 | 879.200 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 08.09.2026 | Verkauf | 195,60 | 4.120 | 805.889 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).